The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Scot Garg
Showing 1-20 of 31 articles
Impact of periprocedural major adverse events on 10-year mortality after revascularisation
Kotoku N,
Serruys P,
Ninomiya K,
Soo A,
Masuda S,
Kageyama S,
Revaiah P,
Mack M,
Holmes DR,
Morice M,
Davierwala P,
Mohr F,
Milojevic M,
Kappetein A,
Garg S,
Onuma Y
March 20, 2023 | 10.4244/EIJ-D-22-00681
Rocky II, Rambo II, and the ACURATE neo2
Serruys P,
Elkoumy A,
Garg S
January 23, 2023 | 10.4244/EIJ-E-22-00050
Sirolimus-eluting stents with ultrathin struts versus everolimus-eluting stents for patients undergoing percutaneous coronary intervention: final three-year results of the TALENT trial
de Winter RJ,
Zaman A,
Hara H,
Gao C,
Ono M,
Garg S,
Smits P,
Tonino P,
Hofma S,
Moreno R,
Choudhury A,
Petrov I,
Cequier A,
Colombo A,
Kaul U,
Onuma Y,
Serruys P
August 19, 2022 | 10.4244/EIJ-D-21-00766
Ticagrelor monotherapy versus aspirin monotherapy at 12 months after percutaneous coronary intervention: a landmark analysis of the GLOBAL LEADERS trial
Ono M,
Hara H,
Kawashima H,
Gao C,
Wang R,
Wykrzykowska JJ,
Piek J,
Garg S,
Hamm C,
Steg PG,
Valgimigli M,
Windecker S,
Vranckx P,
Onuma Y,
Serruys P
August 5, 2022 | 10.4244/EIJ-D-21-00870
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M,
Louvard Y,
Lefèvre T,
Stankovic G,
Burzotta F,
Kassab G,
Lassen J,
Darremont O,
Garg S,
Koo B,
Holm N,
Johnson T,
Pan M,
Chatzizisis Y,
Banning A,
Chieffo A,
Dudek D,
Hildick-Smith D,
Garot J,
Henry T,
Dangas G,
Stone G,
Krucoff M,
Cutlip D,
Mehran R,
Wijns W,
Sharif F,
Serruys P,
Onuma Y
May 18, 2022 | 10.4244/EIJ-E-22-00018
Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trial
Takahashi K,
Chichareon P,
Modolo R,
Kogame N,
Chang C,
Tomaniak M,
Moschovitis A,
Curzen N,
Haude M,
Jung W,
Holmvang L,
Garg S,
Tijssen J,
Wykrzykowska JJ,
de Winter RJ,
Hamm C,
Steg PG,
Stoll H,
Onuma Y,
Valgimigli M,
Vranckx P,
Windecker S,
Serruys P
October 23, 2020 | 10.4244/EIJ-D-19-00498
Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial
Serruys P,
Tomaniak M,
Chichareon P,
Modolo R,
Kogame N,
Takahashi K,
Chang C,
Spitzer E,
Walsh S,
Adlam D,
Hildick-Smith D,
Édes I,
van de Harst P,
Krackhardt F,
Tijssen J,
Rademaker-Havinga T,
Garg S,
Steg PG,
Hamm C,
Jüni P,
Vranckx P,
Onuma Y,
Verheugt F
December 20, 2019 | 10.4244/EIJ-D-19-00202
Validation of the updated logistic clinical SYNTAX score for all-cause mortality in the GLOBAL LEADERS trial
Chichareon P,
Onuma Y,
van Klaveren D,
Modolo R,
Kogame N,
Takahashi K,
Chang C,
Tomaniak M,
Asano T,
Katagiri Y,
van Geuns R,
Bolognese L,
Tumscitz C,
Vrolix M,
Petrov I,
Garg S,
Naber C,
Sabaté M,
Iqbal J,
Wykrzykowska JJ,
Piek J,
Spitzer E,
Jüni P,
Hamm C,
Steg PG,
Valgimigli M,
Vranckx P,
Windecker S,
Serruys P
August 9, 2019 | 10.4244/EIJ-D-19-00184
Interventional cardiology: review of the year 2017
Modolo R,
Miyazaki Y,
Chichareon P,
Asano T,
Collet C,
Tenekecioglu E,
Katagiri Y,
Soliman O,
Garg S,
Onuma Y,
Serruys P
April 20, 2018 | 10.4244/EIJ-D-18-00066
How should I treat a patient with giant left main coronary artery aneurysm without associated stenosis?
Ormerod J,
Lim J,
Chandrasekaran B,
Ramcharitar S,
Garg S,
Singh R,
McDonald J,
Balachandran K,
Wykrzykowska JJ
January 20, 2016 | 10.4244/EIJV11I9A217
The FIREHAWK® stent: will it achieve its potential?
Garg S
May 21, 2013 | 10.4244/EIJV9I1A2
Cardiovascular risk profile of patients included in stent trials; a pooled analysis of individual patient data from randomised clinical trials: insights from 33 prospective stent trials in Europe
Vranckx P,
Boersma E,
Garg S,
Valgimigli M,
Van Es G-A,
Goedhart D,
Serruys P
November 30, 2011 | 10.4244/EIJV7I7A134
How should I treat impaired systolic function and clinical deterioration after surgery of type A aortic dissection?
Gutiérrez-Chico J-L,
Garcia-Garcia H,
Ligthart J,
Bol-Raap G,
Garg S,
Bekkers J,
Serruys P
September 30, 2011 | 10.4244/EIJV7I5A102
Implantation of the biodegradable polymer biolimus-eluting stent in patients with high SYNTAX score is associated with decreased cardiac mortality compared to a permanent polymer sirolimus-eluting stent: two year follow-up results from the “all-comers” LEADERS trial
Wykrzykowska JJ,
Garg S,
Onuma Y,
de Vries T,
Morel M,
Van Es G-A,
Buszman P,
Linke A,
Ischinger T,
Klauss V,
Corti R,
Eberli F,
Wijns W,
Morice M,
Di Mario C,
van Geuns R,
Jüni P,
Windecker S,
Serruys P
September 30, 2011 | 10.4244/EIJV7I5A97
Moxy® drug-coated balloon: a novel device for the treatment of coronary and peripheral vascular disease
Gutiérrez-Chico J-L,
Regar E,
van Geuns R,
Garg S,
Schultz C,
Van Mieghem N,
Duckers H,
Serruys P
June 30, 2011 | 10.4244/EIJV7I2A44
Five-year outcomes of percutaneous coronary intervention compared to bypass surgery in patients with multivessel disease involving the proximal left anterior descending artery: an ARTS-II sub-study
Garg S,
Sarno G,
Gutiérrez-Chico J-L,
Garcia-Garcia H,
Gomez-Lara J,
Serruys P
April 20, 2011
Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study
Brugaletta S,
Garcia-Garcia H,
Diletti R,
Gomez-Lara J,
Garg S,
Onuma Y,
Shin E,
van Geuns R,
De Bruyne B,
Dudek D,
Thuesen L,
Chevalier B,
McClean D,
Windecker S,
Whitbourn R,
Dorange C,
Veldhof S,
Rapoza R,
Sudhir K,
Bruining N,
Ormiston J,
Serruys P
April 20, 2011
The outcome of bifurcation lesion stenting using a biolimuseluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer
Garg S,
Wykrzykowska JJ,
Serruys P,
de Vries T,
Buszman P,
Trznadel S,
Linke A,
Lenk K,
Ischinger T,
Klauss V,
Eberli F,
Corti R,
Wijns W,
Morice M,
Di Mario C,
Tyczynski P,
van Geuns R,
Eerdmans P,
Van Es G-A,
Meier B,
Jüni P,
Windecker S
March 21, 2011
Intravascular ultrasound radiofrequency analysis after optimal coronary stenting with initial quantitative coronary angiography guidance: an ATHEROREMO sub-study
Sarno G,
Garg S,
Gomez-Lara J,
Garcia-Garcia H,
Ligthart J,
Bruining N,
Onuma Y,
Witberg K,
van Geuns R,
de Boer S,
Wykrzykowska JJ,
Schultz C,
Duckers H,
Regar E,
de Jaegere P,
de Feyter P,
Van Es G-A,
Boersma E,
van der Giessen WJ,
Serruys P
March 21, 2011
Influence of age on the clinical outcomes of coronary revascularisation for the treatment of patients with multivessel de novo coronary artery lesions: sirolimus-eluting stent vs. coronary artery bypass surgery and bare metal stent, insight from the multicentre randomised Arterial Revascularisation Therapy Study Part I (ARTS-I) and Part II (ARTS-II)
Legrand V,
Garg S,
Serruys P,
Virtanen K,
Szurawitzki G,
Voudris V,
Fontanelli A,
Endersen K,
Kranjec I,
Rademaker T,
Stefanadis C,
Wittebols K
February 21, 2011
1
2
Latest news
AHEAD OF PRINT
Diagnostic accuracy of OFR
FREE ARTICLE - Fukang Hu et al
March 23, 2023
#EIJonAir - Renal denervation in the management of hypertension
March 22, 2023
NEW ISSUE
ESC/EAPCI Consensus Statement on Renal Denervation; the Future of TMVR; Mini-focus on Interventional Pharmacology...
March 20, 2023
AHEAD OF PRINT
Contemporary transcatheter prostheses in small annuli
FREE ARTICLE - Pier Pasquale Leone et al
March 21, 2023
AHEAD OF PRINT
Early changes in cardiac damage after TAVI
FREE ARTICLE - Yaoyao Zhou et al
March 17, 2023
AHEAD OF PRINT
Posterior pericardiotomy for the prevention of atrial fibrillation
FREE ARTICLE - Ahmed AbdelAziz et al
March 16, 2023
AHEAD OF PRINT
One-year outcomes with the Mistral device
FREE ARTICLE - Kerstin Piayda et al
March 13, 2023
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke